Keywords
chronic kidney disease, lipid spectrum, dyslipidemia, LDL, HDL, triglycerides
Abstract
The purpose of this study was to study the characteristics of lipid metabolism in patients with stage 1-3 chronic kidney disease (CKD). The study included 74 people divided into three groups: patients with CKD, patients with chronic inflammatory kidney disease without signs of CKD, and healthy individuals. It has been shown that patients with CKD have significant changes in the lipid spectrum towards atherogenic dyslipidemia, starting from the early stages of the
disease. Patients without signs of CKD also showed moderate lipid metabolism disorders. The findings emphasize the need for early diagnosis and correction of dyslipidemia for the prevention of cardiovascular complications.